• CAS编号
  • 中文/英文品名
  • 货号/编号
关于甄准 | 设为首页 | 加入收藏
产品分类>>更多
联系我们
 
推荐产品当前位置:首 页 > 产品中心 > 热销推荐产品 > 推荐产品

 
CAS NO:N/A
 
产品货号:ZS-31000----ZS-31077
中文名:大环螯合剂 系列产品
英文名:macrocyclic chelating agents
规格:N/A
浓度/纯度:N/A
货期:4-6周
价格:0
产品描述
 

货号 简称 化学名 CAS 纯度 价格
双官能团螯合剂 (BFCs)
ZS-31000 p-SCN-Bn-TCMC S-2-(4-Isothiocyanatobenzyl)-1,4,7,10-tetraaza-1,4,7,10-tetra(2-carbamoylmethyl)cyclododecane .282097-63-6 ≥ 94% 7000/50mg; 11172/100mg; 
ZS-31001 p-NO2-Bn-Cyclen S-2-(4-Nitrobenzyl)-1,4,7,10-tetraazacyclododecane; .116052-96-9 ≥ 94% 7434/100mg; 25984/500mg; 
ZS-31002 DOTAM-mono-acid 1,4,7,10-Tetraazacyclododecane-1,4,7-tri(carbamoylmethyl)-10-acetic acid; N/A ≥ 95% 7000/100mg; 15960/500mg; 
ZS-31003 p-NO2-Bn-DOTA S-2-(4-Nitrobenzyl)-1,4,7,10-tetraazacyclododecane tetraacetic acid; .116052-88-1 ≥ 94% 5866/50mg; 8120/100mg; 
ZS-31004 p-NH-Bn-DOTA S-2-(4-Aminobenzyl)-1,4,7,10-tetraazacyclododecane tetraacetic acid; .181065-46-3 ≥ 94% 5810/50mg; 8036/100mg; 26068/500mg 
ZS-31005 p-NH-Bn-DOTA-tetra(t-Bu ester) S-2-(4-Aminobenzyl)-1,4,7,10-tetraazacyclododecane tetra-tert-butylacetate; N/A ≥ 94% 6482/100mg; 21840/500mg; 
ZS-31006 p-SCN-Bn-DOTA S-2-(4-Isothiocyanatobenzyl)-1,4,7,10-tetraazacyclododecane tetraacetic acid; .127985-74-4 ≥ 94% 6720/50mg; 9128/100mg; 30422/500mg 
ZS-31007 DOTA-tris (t-Bu ester) 1,4,7,10-Tetraazacyclododecane-1,4,7-tris-tert-butyl acetate-10-acetic acid; .137076-54-1 ≥ 95% 6034/500mg; 8246/1g; 29764/5g 
ZS-31008 DOTAGA-tetra (t-Bu ester) 2-[1,4,7,10-Tetraazacyclododecane-4,7,10-tris(t-butyl acetate)]-pentanedioic acid-1t-butyl ester; .306776-79-4 ≥ 94% 6160/100mg; 11340/500mg; 16030/1g 
ZS-31009 DOTA-mono-NHS tris (t-Bu ester) 1,4,7,10-Tetraazacyclododecane-1,4,7-tris-tert-butyl acetate-10-succinimidyl acetate; .819869-77-7 ≥ 94% 3500/100mg; 8232/500mg; 13552/1g 
ZS-31010 Maleimido-mono-amide-DOTA-tris (t-Bu ester) 1,4,7,10-Tetraazacyclododecane-1,4,7-tris-tert-butyl acetate-10-maleimidoethylacetamide; N/A ≥ 94% 4928/50mg; 6608/100mg; 15428/500mg 
ZS-31011 Maleimido-mono-amide-DOTA 1,4,7,10-Tetraazacyclododecane-1,4,7-tris-acetic acid-10-maleimidoethylacetamide; .1006711-09-5 ≥ 94% 5292/50mg; 6972/100mg; 16646/500mg 
ZS-31012 Fmoc-L-Lys-mono-amide-DOTA-tris(t-Bu ester) 1,4,7,10-Tetraazacyclododecane-1,4,7-tris-tert-butyl acetate-10-(N-a-Fmoc-N-e-acetamido-L-lysine); .479081-06-6 ≥ 94% 4872/50mg; 6454/100mg; 15344/500mg 
ZS-31013 Butyne-DOTA-tris(t-butyl ester) 1,4,7,10-Tetraazacyclododecane-1,4,7-tris(t-butyl acetate)-10-(3-butynylacetamide); N/A ≥ 94% 4928/100mg; 13244/500mg; 
ZS-31014 2-Aminoethyl-mono-amide-DOTA-tris(t-Bu ester) 1,4,7,10-Tetraazacyclododecane-1,4,7-tris(t-butyl-acetate)-10-(aminoethylacetamide); N/A ≥ 94% 7126/500mg; 11130/1g; 37982/5g 
ZS-31015 Azido-mono-amide-DOTA-tris(t-Bu ester) 1,4,7,10-Tetraazacyclododecane-1,4,7-tris-tert-butyl acetate-10-(azidopropyl ethylacetamide); N/A ≥ 94% 4928/100mg; 13384/500mg; 22596/1g 
ZS-31016 4-Aminobutyl-DOTA-tris (t-butyl ester) 1,4,7,10-Tetraazacyclododecane-1,4,7-tris(t-butyl acetate)-10-(4-aminobutyl)acetamide; N/A ≥ 94% 5096/100mg; 12376/500mg; 
ZS-31017 DOTA-NHS-ester 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid mono-N-hydroxysuccinimide ester; .170908-81-3 ≥ 90% 3850/100mg; 8974/500mg; 15078/1g 
ZS-31018 DO3A-Thiol 1,4,7,10-Tetraazacyclododecane-1,4,7-tris(acetic acid)-10-(2-thioethyl)acetamide; .865470-67-3 ≥ 94% 13804/100mg; 41804/500mg; 
ZS-31019 Butyne-DOTA 1,4,7,10-Tetraazacyclododecane-1,4,7-tris(acetic acid)-10-(3-butynylacetamide); N/A ≥ 94% 6244/100mg; 18242/500mg; 
ZS-31020 Azido-mono-amide-DOTA 1,4,7,10-Tetraazacyclododecane-1,4,7-tris(acetic acid)-10-(azidopropyl ethylacetamide); .1227407-76-2 ≥ 94% 6062/100mg; 17892/500mg; 30800/1g 
ZS-31021 4-Aminobutyl-DOTA 1,4,7,10-Tetraazacyclododecane-1,4,7-tris(acetic acid)-10-(4-aminobutyl)acetamide; N/A ≥ 94% 6454/100mg; 19096/500mg; 
ZS-31023 p-NH-Bn-DTPA-penta (t-Bu ester) S-2-(4-Aminobenzyl)-diethylenetriamine penta-tert-butyl acetate; .205956-41-0 ≥ 94% 20832/1g;
ZS-31024 p-SCN-Bn-DTPA S-2-(4-Isothiocyanatobenzyl)-diethylenetriamine pentaacetic acid; .102650-30-6 ≥ 94% 4802/100mg; 14028/500mg; 
ZS-31025 p-NH-Bn-CHX-A”-DTPA [(R)-2-Amino-3-(4-aminophenyl)propyl]-trans-(S,S)-cyclohexane-1,2-diamine-pentaacetic acid; .1105741-38-5 ≥ 94% 7574/100mg; 23296/500mg; 
ZS-31026 p-SCN-Bn-CHX-A”-DTPA [(R)-2-Amino-3-(4-isothiocyanatophenyl)propyl]-trans-(S,S)-cyclohexane-1,2-diamine-pentaacetic acid; .157380-45-5 ≥ 94% 6146/50mg; 8260/100mg; 24752/500mg 
ZS-31027 DTPA-tetra (t-Bu ester) Diethylenetriamine-N,N,N”,N”-tetra-tert-butyl acetate-N’-acetic acid; .174267-71-1 ≥ 94% 11984/500mg; 20286/1g; 
ZS-31028 Maleimido-mono-amide-DTPA Diethylenetriamine-N,N,N”,N”-tetra- acetic acid-N’-maleimidoethylacetamide; N/A ≥ 94% 6860/50mg; 9716/100mg; 28070/500mg 
ZS-31029 p-NH-Bn-PCTA 3,6,9,15-Tetraazabicyclo[9.3.1] pentadeca-1(15),11,13-triene-4-S-(4-aminobenzyl)-3,6,9-triacetic acid; N/A ≥ 94% 7392/50mg; 9786/100mg; 
ZS-31030 p-SCN-Bn-PCTA 3,6,9,15-Tetraazabicyclo[9.3.1] pentadeca-1(15),11,13-triene-4-S-(4-isothiocyanatobenzyl)-3,6,9-triacetic acid; N/A ≥ 94% 8568/50mg; 10850/100mg; 
ZS-31031 p-NH-Bn-oxo-DO3A 1-Oxa-4,7,10-tetraazacyclododecane-5-S-(4-aminobenzyl)-4,7,10-triacetic acid; N/A ≥ 94% 7392/50mg; 9786/100mg; 
ZS-31032 p-SCN-Bn-oxo-DO3A 1-Oxa-4,7,10-tetraazacyclododecane-5-S-(4-isothiocyantobenzyl)-4,7,10-triacetic acid; N/A ≥ 94% 8400/50mg; 10626/100mg; 
ZS-31033 p-NH2-Bn-NOTA 2-S-(4-Aminobenzyl)-1,4,7-triazacyclononane-1,4,7-triacetic acid; .142131-37-1 ≥ 94% 5488/50mg; 7672/100mg; 
ZS-31034 p-SCN-Bn-NOTA 2-S-(4-Isothiocyanatobenzyl)-1,4,7-triazacyclononane-1,4,7-triacetic acid; .147597-66-8 ≥ 94% 7000/50mg; 9492/100mg; 
ZS-31035 NO2A-Butyne-bis (t-Butyl ester) 1,4,7-Triazacyclononane-1,4-bis(t-butylacetate)-7-(3-butynylacetamide); N/A   13244/100mg; 39942/500mg; 
ZS-31036 NOTA-bis(t-Bu ester) 1,4,7-Triazacyclononane-1,4-bis-tert-butyl acetate-7-acetic acid; .1161415-28-6 ≥ 95% 4872/100mg; 13538/500mg; 18004/1g 
ZS-31037 Maleimido-mono-amide-NOTA 1,4,7-Triazacyclononane-1,4-bis-acetic acid-7-maleimidoethylacetamide; N/A ≥ 94% 8652/100mg; 21168/500mg; 
ZS-31038 NO2A-Butyne 1,4,7-Triazacyclononane-1,4-bis(acetic acid)-7-(3-butynylacetamide); N/A ≥ 94% 18242/100mg; 58576/500mg; 
ZS-31039 NO2A-Azide 1,4,7-Triazacyclononane-1,4-bis(acetic acid)-7-(3-azidopropylacetamide); N/A ≥ 94% 8960/100mg; 22036/500mg; 
ZS-31040 p-SCN-Bn-Deferoxamine 1-(4-isothiocyanatophenyl)-3-[6,17-dihydroxy-7,10,18,21-tetraoxo-27-(N-acetylhydroxylamino)- 6,11,17, 22- tetraazaheptaeicosine] thiourea; .1222468-90-7 ≥ 94% 5852/50mg; 8022/100mg; 22568/500mg 
ZS-31041 Deferoxamine-maleimide N-(3,11,14,22,25,33-hexaoxo-4,10,15,21,26,32-hexaaza-10,21,32- trihydroxytetratriacontane)maleimide; N/A ≥ 94% 5208/50mg; 7014/100mg; 19054/500mg 
轭合物
ZS-31042 DOTA-Biotin-Sarcosine (N-methyl-N-(hexahydro-2-oxo-1H-thieno[3,4-d]-imidazol-4-yl)-oxopentyl)glycyl-2-(S)-(4-aminobenzyl)-1,4,7,10-tetraacetic acid-1,4,7,10-tetraazacyclododecane; N/A ≥ 94% 7868/20mg; 14196/50mg; 25676/100mg 
ZS-31043 DO3A-Serotonin 1-(5-Hydroxyindole-3-ethylacetamide)-4,7,10-triacetic acid-1,4,7,10-tetraazacyclododecane; N/A ≥ 94% 7812/100mg; 25088/500mg; 
ZS-31044 DOTATATE DOTA-d-Phe-Cys-Tyr-d-Trp-Lys-Thr-Cys-Thr; .177943-89-4 ≥ 95% 9800/1mg; 
大环化合物配体
ZS-31047 TACN 1,4,7-Triazacyclononane; .4730-54-5 ≥ 95% 3892/1g ;10290/5g; 
ZS-31048 Cyclen 1,4,7,10-Tetraazacyclododecane; .294-90-6 Crystalline 5530/5g ;8876/10g; 17150/25g 
ZS-31049 DO2A 1,4,7,10-Tetraazacyclododecane-1,7-diacetic acid; .112193-75-6 N/A 8834/500mg; 14294/1g; 
ZS-31050 DO3A 1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid trisodium salt; .217973-03-0 ≥ 95% 7294/500mg; 11172/1g; 
ZS-31051 DOTA 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid; .60239-18-1 ≥ 95% 4116/1g ;10682/5g; 37618/25g 
ZS-31052 DOTP 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetra(methylene phosphonic acid); .91987-74-5 ≥ 95% 3318/1g ;5992/5g; 9324/10g 
ZS-31053 DOTMA (1R, 4R, 7R, 10R)-α, α’, α”, α’”-Tetramethyl-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid tetrasodium salt; .148408-89-3 ≥ 95% 4452/100mg; 9464/500mg; 15260/1g 
ZS-31054 TETA 1,4,8,11-Tetraazacyclotetradecane-1,4,8,11-tetraacetic acid; .314041-07-1 ≥ 95% 8988/500mg; 14658/1g; 54530/5g 
ZS-31055 DOTAM 1,4,7,10-Tetrakis(carbamoylmethyl)-1,4,7,10-tetraazacyclododecane; .157599-02-5 ≥ 95% 2842/500mg; 3472/1g; 8526/5g 
ZS-31056 DiAmSar 1,8-Diamino-3,6,10,13,16,19-hexaazabicyclo[6,6,6]-eicosane; .91002-72-1 Crystalline 6384/100mg; 16198/500mg; 
ZS-31057 CB-Cyclam 1,4,8,11-Tetraazabicyclo[6.6.2]hexadecane; .130701-19-8 N/A 8106/500mg; 11424/1g; 
ZS-31058 CB-TE2A 1,4,8,11-Tetraazabicyclo[6.6.2]hexadecane-4,11-diacetic acid; .313229-90-2 N/A 3682/100mg; 8414/500mg; 
ZS-31059 DOTA-4AMP 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(acetamido-methylenephosphonic acid); N/A ≥ 94% 7238/100mg; 15386/500mg; 
ZS-31060 NOTA 1,4,7-Triazacyclononane-1,4,7-triacetic acid; .56491-86-2 ≥ 95% 9352/500mg; 12572/1g; 
ZS-31061 NOTP 1,4,7-Triazacyclononane-1,4,7-tri(methylene phosphonic acid); .83834-39-3 ≥ 95% 4886/1g ;13958/5g; 
磁共振造影剂
ZS-31062 Tm-DOTA Thulium (III) 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetate; N/A ≥ 94% 5166/500mg; 7742/1g; 
ZS-31063 Gd-DOTA Gadolinium (III) 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetate; N/A N/A 4844/500mg; 6930/1g; 
ZS-31064 Tm-DOTP Thulium (III) 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetra(methylenephosphonate); .30859-88-8 N/A 4284/1g ;20034/10g; 167930/100g 
ZS-31065 Tm-DOTMA Thulium (III) (1R, 4R, 7R, 10R)-α, α’, α”, α’”-Tetramethyl-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid; N/A ≥ 94% 13538/500mg; 19922/1g; 
ZS-31066 Eu-DOTA-4AmC Europium (III) 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetrakis(acetamidoacetic acid); N/A ≥ 95% 4326/50mg; 6048/100mg; 11172/500mg 
ZS-31067 Tm-p-SCN-Bn-DOTA Thulium (III) S-2-(4-isothiocyanatobenzyl)-1,4,7,10-_x000D_
tetraazacyclododecane-1,4,7,10-tetraacetic acid;
N/A ≥ 94% 11858/50mg; 18746/100mg; 
ZS-31068 Gd-p-SCN-Bn-DOTA Gadolinium (III) S-2-(4-isothiocyanatobenzyl)-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid; N/A ≥ 94% 11858/50mg; 18746/100mg; 
ZS-31069 Ho-p-SCN-Bn-DOTA Holmium (III) S-2-(4-isothiocyanatobenzyl)-1,4,7,10-_x000D_
tetraazacyclododecane-1,4,7,10-tetraacetic acid;
N/A ≥ 94% 11858/50mg; 18746/100mg; 
ZS-31070 Tm-Maleimido-DOTA  
Thulium (III) 1,4,7,10-tetraazacyclododecane-1,4,7-tris(acetic acid)-10-_x000D_
maleimidoethylacetamide;
N/A ≥ 94% 8554/50mg; 13328/100mg; 
ZS-31071 Ho-Maleimido-DOTA Holmium (III) 1,4,7,10-tetraazacyclododecane-1,4,7-tris(acetic acid)-_x000D_
10-maleimidoethylacetamide;
N/A ≥ 94% 8554/50mg; 13328/100mg; 
ZS-31072 Gd-DO3A-Butylamine Gadolinium (III) 1,4,7,10-Tetraazacyclododecane-1,4,7-tris(acetic acid)-10-(4-aminobutyl)acetamide; N/A ≥ 94% 9030/100mg; 29092/500mg; 
活性中间体
ZS-31073 Bis-CBZ-Cyclen 1,4,7,10-Tetraazacyclododecane-1,7-bis(benzylcarbamide); N/A ≥ 95% 6384/1g ;19096/5g; 
ZS-31074 Tris-BOC-Cyclen 1,4,7,10-Tetraazacyclododecane-1,4,7-tris(t-butoxycarbonyl); N/A ≥ 95% 4466/1g ;12740/5g; 
ZS-31075 NO2A-(t-Bu ester) 1,4,7-Triazacyclononane-1,4-bis(t-butyl acetate); .174137-97-4 ≥ 95% 9198/500mg; 14000/1g; 
ZS-31076 DO2A-tert-butyl ester 1,4,7,10-Tetraazacyclododecane-1,7-bis(t-butyl acetate); .162148-48-3 ≥ 95% 4480/500mg; 5768/1g; 17458/5g 
ZS-31077 DO3A-tert-butyl ester 1,4,7,10-Tetraazacyclododecane-1,4,7-tris(t-butyl acetate); .122555-91-3 ≥ 95% 3416/500mg; 3892/1g; 9968/5g